SCHEMBL7229858

SCHEMBL7229858

COC(=O)c1n[nH]nc1C(=O)Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
NPSR1 Q6W5P4 2/20 0.48
KDM4C Q9H3R0 1/20 0.44
KDM4E B2RXH2 2/20 0.40
STAT3 P40763 1/20 0.40
HIF1A Q16665 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPK1 P28482 1/20 0.36
ALPL P05186 1/20 0.33
MAPT P10636 3/20 0.33
CYP1A2 P05177 1/20 0.32
HSD17B10 Q99714 2/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
GAA P10253 2/20 0.31
ERCC1 P07992 1/20 0.31
FEN1 P39748 1/20 0.31
ERCC4 Q92889 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6440860 0.89 NPSR1 (0.59) SMN1; SMN2NPSR1KDM4CKDM4ESTAT3
SCHEMBL6440864 0.81 SMN1; SMN2 (0.56) SMN1; SMN2NPSR1KDM4CKDM4ESTAT3
SCHEMBL1412516 0.77 SMN1; SMN2 (0.51) SMN1; SMN2NPSR1KDM4CKDM4ESTAT3
SCHEMBL17627087 0.75 SMN1; SMN2 (0.50) SMN1; SMN2NPSR1KDM4CKDM4ESTAT3
SCHEMBL31436306 0.75 SMN1; SMN2 (0.50) SMN1; SMN2NPSR1KDM4CKDM4ESTAT3
SCHEMBL1930473 0.69 NPSR1 (0.46) SMN1; SMN2NPSR1KDM4CKDM4EL3MBTL1
SCHEMBL8951086 0.66 NPSR1 (1.00) SMN1; SMN2NPSR1KDM4CKDM4ESTAT3
SCHEMBL983024 0.65 NPSR1 (0.46) SMN1; SMN2NPSR1KDM4CKDM4ESTAT3
SCHEMBL1256960 0.65 SMN1; SMN2 (0.72) SMN1; SMN2KDM4EL3MBTL1ALDH1A1MAPT
SCHEMBL17766421 0.64 HCAR2 (0.63) SMN1; SMN2NPSR1KDM4CKDM4ESTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030055263-A1 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055263-A1 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production TERT, POT1, REV1 SMN1; SMN2 1306/4885NPSR1 4318/4885KDM4C 4712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.